About: Trend Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in 16 Cities of Hubei Province, China

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Trend Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in 16 Cities of Hubei Province, China Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Trend Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in 16 Cities of Hubei Province, China
Creator	Ren, Jingli Fawad, Muhammad Yu, Chuanhua Hao, Yangyang Mubarik, Sumaira Shakil, Saima
Source	Medline; PMC
abstract	OBJECTIVE: A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was detected by researchers from a patient in Wuhan, Hubei province, China, in December 2019, and broke out in January 2020. Then, the pandemic was detected in countries around the world. Therefore, precise estimates of its current and future trends are highly required for future policy implications. METHODS: We retrieved data from the Health Commission of Hubei, China. Logistic-S curve model was used to estimate the current and future trends of SARS-CoV-2-infected cases among 16 cities of Hubei, China from Jan-11 to Feb-24, 2020. RESULTS: Out of 64,287 confirmed cases of SARS-CoV-2 infection in Hubei, higher percentage of cases were in Wuhan and Xiaogan. The highest death percentage was found in Wuhan and Qianjiang. A significant percentage of cures were found in Enshi Prefecture and Huanggang, while Wuhan showed the lowest percentage of cures. Rising trends in infected cases were observed throughout the study period, particularly in Wuhan, and a higher trend was observed after 12-Feb. Gradual decline trend of SARS-CoV-2 cases was observed during Feb-25 to Mar-15 in Hubei Province. Future forecast showed that the average number of SARS-CoV-2-infected cases might be decreased or stable in Hubei in the coming 20 days. CONCLUSION: The public must take precautionary measures in order to control and prevent disease spread and avoid extra travelling.
has issue date	2020-07-02(xsd:dateTime)
bibo:doi	10.2147/clep.s254806
bibo:pmid	32669878
has license	cc-by-nc
sha1sum (hex)	e4bb1b30523d1f0fab7acb0111e64f56f8a92365
schema:url	https://doi.org/10.2147/clep.s254806
resource representing a document's title	Trend Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in 16 Cities of Hubei Province, China
has PubMed Central identifier	PMC7337437
has PubMed identifier	32669878
schema:publication	Clin Epidemiol
resource representing a document's body	covid:e4bb1b30523d1f0fab7acb0111e64f56f8a92365#body_text
is schema:about of	named entity 'Transmission' named entity 'Hubei Province, China' named entity 'China' named entity 'WHO' named entity 'Severe acute respiratory syndrome' named entity 'SARS-CoV-2' named entity 'MAD' named entity 'Enshi Prefecture' named entity 'Iran' named entity 'lopinavir/ritonavir' named entity 'preventive measures' named entity 'time series' named entity 'Hubei' named entity 'SARS-CoV-2' named entity 'endonuclease' named entity 'Wuhan' named entity 'SARS-CoV-2' named entity 'pandemics' named entity 'Wuhan' named entity 'SARS-CoV-2' named entity 'public health' named entity 'United States' named entity 'SARS-CoV-2' named entity 'coronavirus' named entity 'MERS' named entity 'nitazoxanide' named entity 'China' named entity 'Pakistan' named entity 'SARS-CoV-2' named entity 'Wuhan' named entity 'lockdown' named entity 'SARS-CoV-2' named entity 'China' named entity 'SARS-CoV-2' named entity 'Enshi Prefecture' named entity 'vaccines' named entity 'viral outbreak' named entity 'hydroxychloroquine' named entity 'epidemic diseases' named entity 'antiviral agents' named entity 'social distancing' named entity 'S-curve' named entity 'China' named entity 'anti-viral drugs' named entity 'S-curve' named entity 'sub-types' named entity 'mutation' named entity 'Qianjiang' named entity 'disease prevalence' named entity 'SARS-CoV-2' named entity 'China' named entity 'Wuhan' named entity 'reservoir 1' named entity 'Xiaogan' named entity 'chloroquine' named entity 'MAPE' named entity 'clinical presentation' named entity 'SARS-CoV-2' named entity 'China' named entity 'Coronavirus' named entity 'China' named entity 'Wuhan' named entity 'SARS-CoV-2' named entity 'viral infection' named entity 'China' named entity 'Thailand' named entity 'SARS-CoV-2' named entity 'pathogen' named entity 'SARS-CoV-2' named entity 'Hubei' named entity 'Enshi Prefecture' named entity 'lower respiratory tract' named entity 'virus' named entity 'Huanggang' named entity 'SARS-CoV-2' named entity 'Wuhan'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software